For example, in Non-Hodgkin Lymphoma (NHL) and in Chronic Lymphocytic Leukemia (CLL), significant up-regulation of PIM-2 was observed [10]. This evidence concerns the gene PIM2 and B-cell chronic lymphocytic leukemia.